Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Sepsis
BioMĂ©rieux receives 510(k) certification for antimicrobial testing system
By
LabPulse.com staff writers
BioMĂ©rieux has received 510(k) clearance from the U.S. Food and Drug Administration for its Vitek Reveal AST system, which reports antimicrobial susceptibility testing (AST) results directly from positive blood cultures.
August 21, 2024
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By
LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By
Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
By
Matt Limb
Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.
January 26, 2024
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
By
LabPulse.com staff writers
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By
Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Cytovale raises $84M in series C funding
By
LabPulse.com staff writers
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Some emergency sepsis screening tools inadequate, EU study suggests
By
Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Nonprofit health system adopts Immunexpress test for detecting sepsis
By
Nick Paul Taylor
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
By
Leo O'Connor
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
T2 Biosystems seeking FDA breakthrough device designation for Candida auris test
By
LabPulse.com staff writers
The Lexington, MA-based maker of a molecular platform and tests for sepsis and other bloodstream infections recently announced plans to add Candida auris detection to its FDA-cleared T2Candida Panel.
June 6, 2023
Page 1 of 6
Next Page
